A8U-19156-37298
4 vaccinations
5 coded responses
28 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 209 / MD
- Registered
- 2021-12-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-14
Dose 1 — Pfizer-BioNTech
-
2021-04-04
Dose 2 — Pfizer-BioNTech
-
2021-12-18
Dose 3 — Pfizer-BioNTech
-
2021-12-19
Registered in v-safe
-
2021-12-19
Survey response — days 1–6 daily, dose 3MedDRA: Grip strength decreased — Feeling: Poor · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Reduced grip strength (may be connected to joint pain)MedDRA releases: 2024-11 · check-in free text available
-
2021-12-20
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Chills, Muscle or body achesAdult check-in
- 2021-12-21
- 2021-12-22
- 2021-12-23
- 2021-12-24
- 2021-12-25
- 2022-01-01
- 2022-01-08
-
2022-01-15
Survey response — day 28, dose 3MedDRA: Disturbance in attention, Fatigue, Insomnia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Insomnia, tiredness, difficulty to focusMedDRA releases: 2024-11 · check-in free text available
- 2022-01-22
- 2022-01-29
- 2022-03-21
- 2022-06-18
-
2022-09-23
Dose 4 — Pfizer-BioNTech
-
2022-09-24
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-09-25
-
2022-09-26
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-09-27
- 2022-09-28
- 2022-09-29
- 2022-10-01
-
2022-10-09
Survey response — day 14, dose 4MedDRA: Cognitive disorder, Disturbance in attention, Nasal congestion, Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I caught a cold last week (stuffy nose, low brain function/concentration, headaches, a tiny cough) but I tested several times and it was negative for COVIDMedDRA releases: 2024-11 · check-in free text available
- 2022-10-14
- 2022-10-21
- 2022-10-29
-
2022-11-04
Survey response — day 42, dose 4MedDRA: Fatigue, Insomnia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Fatigue related to reoccuring insomnia issuesMedDRA releases: 2024-11 · check-in free text available
-
2022-12-24
Survey response — 3 months, dose 4MedDRA: Chest discomfort, Cough, Nasopharyngitis, Oropharyngeal pain, SARS-CoV-2 test negative — Feeling: FairFree text: I currently have cold symptoms - sore throat, tight chest, mild cough - but have tested negative for COVID-19MedDRA releases: 2024-11 · check-in free text available
- 2023-03-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-14 | Pfizer-BioNTech | No |
| 2 | 2021-04-04 | Pfizer-BioNTech | No |
| 3 | 2021-12-18 | Pfizer-BioNTech | No |
| 4 | 2022-09-23 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Reduced grip strength (may be connected to joint pain)
Release 10 — day 28, dose 3
Symptoms: Insomnia, tiredness, difficulty to focus
Release 12 — day 14, dose 4
Symptoms: I caught a cold last week (stuffy nose, low brain function/concentration, headaches, a tiny cough) but I tested several times and it was negative for COVID
Release 12 — day 42, dose 4
Symptoms: Fatigue related to reoccuring insomnia issues
Release 12 — 3 months, dose 4
Symptoms: I currently have cold symptoms - sore throat, tight chest, mild cough - but have tested negative for COVID-19
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chest discomfort | · | · | ✓ |
| SD | Cognitive disorder | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Disturbance in attention | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Insomnia | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Grip strength decreased | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release